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Abstract
Background: Dendritic cells (DCs) are the sentinels of the mammalian immune system,
characterized by a complex maturation process driven by pathogen detection. Although multiple
studies have described the analysis of activated DCs by transcriptional profiling, recent findings
indicate that mRNAs are also regulated at the translational level. A systematic analysis of the
mRNAs being translationally regulated at various stages of DC activation was performed using
translational profiling, which combines sucrose gradient fractionation of polysomal-bound mRNAs
with DNA microarray analysis.
Results: Total and polysomal-bound mRNA populations purified from immature, 4 h and 16 h LPS-
stimulated human monocyte-derived DCs were analyzed on Affymetrix microarrays U133 2.0. A
group of 375 transcripts was identified as translationally regulated during DC-activation. In addition
to several biochemical pathways related to immunity, the most statistically relevant biological
function identified among the translationally regulated mRNAs was protein biosynthesis itself. We
singled-out a cluster of 11 large ribosome proteins mRNAs, which are disengaged from polysomes
at late time of maturation, suggesting the existence of a negative feedback loop regulating
translation in DCs and linking ribosomal proteins to immuno-modulatory function.
Conclusion: Our observations highlight the importance of translation regulation during the
immune response, and may favor the identification of novel protein networks relevant for
immunity. Our study also provides information on the potential absence of correlation between
gene expression and protein production for specific mRNA molecules present in DCs.
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Background
Dendritic cells (DCs) are haematopoietic cells specialized
in antigen capture and presentation for initiation of pri-
mary and secondary immune responses. Due to this cen-
tral role in induction and regulation of immunity, they
represent an attractive target for immunotherapy against
various diseases, including cancer and microbial infec-
tions [1]. We recently demonstrated that translation regu-
lation is required for function and survival of mouse
activated DCs [2]. Moreover, emerging evidence indicate
that translation plays a major role in immune regulation
and its dysfunction can lead to pathology [3-5]. Although
several seminal studies have described the use of microar-
rays to define the gene expression and functional signa-
ture of DCs upon pathogen detection [6,7], there were no
attempts to include the additional layer of complexity
brought by translational regulation. As the relationship
between inflammation, innate immunity, and post-tran-
scriptional regulation is becoming clearer [8], we have in
a recent study used a microarray-based screen to identify
the immunologically relevant pathways regulated by miR-
155 in lipopolysaccharide (LPS)-activated human mono-
cyte-derived DC (moDC) [9]. To increase further our
understanding of post-transcriptional regulation and
establish the contribution of translation in the control of
immune response, we carried-out, using Affymetrix
microarrays, a systematic and comparative analysis of
polysome-bound mRNA [10-12] purified from differently
LPS-activated moDCs.
Using this approach, and in addition to several immuno-
logically relevant mRNAs, we identified a network of
ribosomal protein mRNAs being strongly down-modu-
lated at the translational level at late time of DC matura-
tion. Ribosomal proteins are integral components of the
basal cellular machinery involved in protein synthesis,
whose roles have been regarded collectively as important,
but individually disregarded. Recent findings, however,
have demonstrated that components of the translational
apparatus are multifunctional and that several individual
ribosomal proteins play a role in regulating cell growth,
transformation and death [13]. Our results clearly support
these views and underline the importance of these pro-
teins for DC function.
Results and discussion
Translation is regulated in LPS-activated human moDCs
Human monocyte-derived DCs were activated with LPS
and displayed the expected cell surface accumulation of
MHC I, MHC II and CD86 as measured by flow cytometry
(Figure 1A). The rate of protein synthesis in activated
moDCs was monitored with puromycin incorporation
using immunoblot or FACS analysis (SUnSET) [14]. Pro-
tein synthesis intensity was strongly increased upon LPS-
stimulation and peaked at 4 h of activation, prior a steady
decrease to basal levels (Figure 1B and 1C). As the rate-
limiting step in protein synthesis is the initiation of
mRNA translation, we investigated the status of transla-
tion factors involved in the regulation of protein synthe-
sis. Thus, we monitored by immunoblot the
phosphorylation of the alpha-subunit of eukaryotic trans-
lation initiation factor 2 (eIF2α), which prevents the
assembly of ribosomal pre-initiation complexes [15].
Almost complete eIF2α dephosphorylation was detected
between 1 h and 4 h after LPS-stimulation, correlating
with the increase in protein synthesis. Interestingly, after
several hours of LPS-stimulation eIF2α phosphorylation
was recovered and even increased compared to the imma-
ture DC levels. Thus eIF2α phosphorylation is regulated
during the maturation of human moDCs and correlates
well with the regulation of mRNA translation in these
cells.
Translation initiation is also controlled through the stim-
ulation of the PI3 kinase/AKT/mTOR signal transduction
cascade, which leads to the phosphorylation of eIF4E-
binding proteins (4E-BPs) and of the S6 ribosomal pro-
tein (S6) by the ribosomal protein S6 kinase (S6K1) [16].
Both molecules have an important role in regulating cap-
mediated translation and S6 phosphorylation represents a
hallmark of protein synthesis activation. S6 phosphoryla-
tion was monitored in LPS-activated moDCs by immuno-
blot (Figure 1B). We confirmed that S6 phosphorylation
is steadily and strongly increased over time of LPS-expo-
sure and this in a correlated manner to the moDCs matu-
ration phenotype.
Thus, protein synthesis is tightly controlled upon LPS-
sensing by MoDCs and is likely to represent a functionally
important aspect of human DC maturation. Furthermore,
this process implies that specific mRNA molecules might
be translationally regulated in response to eIF2α or S6
phosphorylation under these conditions.
mRNA translational engagement changes at late time 
points of DC-activation
In order to identify mRNA molecules potentially regu-
lated at the translational level, the global engagement of
mRNA molecules on polysomes was measured on LPS-
activated moDCs by translational profiling [10-12].
Actively translated polysome-bound mRNAs (P) were sep-
arated from messenger free ribonucleoproteins (mRNPs,
F) using sucrose gradient fractionation and visualized by
denaturing agarose gel (Figure 2A). Efficient polysome
separation was confirmed by the presence of 5S rRNA in
the lighter fractions of the gradient (lanes 1-3), followed
by fractions where only 18S rRNA was visible (lanes 4-5)
and fractions in which an excess of large ribosomal subu-
nit was detected (28S rRNA >> 18S rRNA, lanes 6-9). From
fraction 11, a constant ratio of 28S over 18S rRNA was
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observed, thus indicating the presence of complete and
functional ribosomes (Polysomes, lanes 11-19). Fractions
11 to 19 were pooled and polysome-bound RNAs were
isolated (P). In parallel, total RNAs (T) were directly puri-
fied from moDCs without fractionation (lane 20). The
integrity of purified RNAs was quantified to an average
RIN-value of 7.6, thereby allowing for successful microar-
rays analysis (Figure 2B) [17].
In addition to non-activated cells (0 h), moDCs at 4 h and
16 h post-LPS stimulation were also chosen, since they
represent two distinct activation states in which protein
synthesis is either increasing (4 h), or decreasing (16 h),
and in which the phosphorylation status of eIF2-α is rad-
ically different. No major difference in the polysomes sed-
imentation profiles was observed after the fractionation of
the various DCs samples, confirming that actively trans-
lated mRNAs are present at all stages of DC maturation
(not shown). To further identify translationally regulated
mRNAs in maturing moDC, expression levels of all poly-
some-bound mRNAs were compared by microarray anal-
ysis (Affymetrix U133 Plus 2.0 GeneChip array
comprising 54'675 probe sets) to those of unfractionated
total mRNAs (translational profiling, Figure 2). Polys-
ome-bound mRNAs (P) and total RNA (T) were isolated
from moDCs generated from four different blood donors
for three LPS activation time points (0 h, 4 h and 16 h),
resulting in a total of twenty-four RNA samples to be ana-
lyzed. In addition to FACS characterization of the cells,
the quality of the samples was further evaluated by com-
paring the total mRNA expression values of several DC-
maturation markers from our experimental setting with
available public databases values obtained under similar
conditions [6]. Transcription of the co-stimulatory mole-
Translation is regulated in LPS-activated moDCsFigure 1
Translation is regulated in LPS-activated moDCs. moDCs were stimulated with LPS for the indicated timepoints and 
after harvesting both the maturation status and protein synthesis were monitored in parallel. (A) The surface accumulation of 
MHC II, CD86 and MHC I, were measured by flow cytometry in immature (black line), 4 h (blue) or 16 h (green) LPS-stimu-
lated moDCs. (B) The rate of protein synthesis was monitored with puromycin incorporation using immunoblots (top). Cells 
extracts were separated by denaturing electrophoresis and analyzed by western blot with antibody to the phosphorylated form 
of eIF2α and the S6 ribosomal protein (bottom). Total eIF2α detection is shown for equal loading control. (C) FACS analysis 
with antibody to puromycin (SUnSET method) to quantify protein synthesis. Data are representative of at least three inde-
pendent experiments, each derived from a different DC preparation.
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cules CD80 and CD86, as well as the MHC I and II
mRNAs were found to be all up-regulated after DC stimu-
lation by LPS (see Additional file 1), thus confirming the
quality of our samples and reliability of our analysis.
Global alterations of total and polysomal-bound mRNA
as a function of time post-LPS was investigated, to obtain
a comprehensive view of translation regulation in
moDCs. The 54'675 probe sets present were first filtered
on expression (signal > 100 in all tested conditions) to
obtain a preliminary list of 7'709 probe sets. The 7'709
probe sets were then selected on fold change (applying a
2-fold cut-off), comparing Polysomal and Total mRNA at
different timepoints. Between 0 h and 4 h post-LPS,
among the 783 transcriptionally up-regulated genes (sig-
nal 0 h < signal 4 h), 662 genes (84%) were shared
between total and polysomal RNA, 51 genes (6%) were
unique to polysomal RNA, and 70 genes (10%) were
unique to total RNA (Figure 3A). Among the 959 tran-
scriptionally down-regulated genes (signal 0 h > signal 4
h), 597 genes (63%) were shared between total and poly-
somal RNA, 165 genes (17%) were unique to polysomal
RNA, and 188 genes (20%) were unique to total RNA (Fig-
ure 3B). Between 4 h and 16 h post-LPS, among the 536
transcriptionally up-regulated genes (signal 4 h < signal
16 h), 456 genes (65%) were shared between total and
polysomal RNA, 91 genes (13%) were unique to polyso-
mal RNA, and 151 genes (22%) were unique to total RNA
(Figure 3C). Similarly, among the 698 transcriptionally
down-regulated genes (signal 4 h > signal 16 h), 355 genes
(66%) were shared between total and polysomal RNA, 55
genes (10%) were unique to polysomal RNA, and 127
genes (24%) were unique to total RNA (Figure 3D). These
results indicate that during DC maturation, transcription
Efficient profiling and isolation of polysomes out of human moDCsFigure 2
Efficient profiling and isolation of polysomes out of human moDCs. Polysomes sedimentation profiles (A) and RNA-
integrity profiles (B) after sucrose gradient fractionation of untreated (0 h) or 4 h and 16 h LPS-stimulated moDCs.
Immunome Research 2009, 5:5 http://www.immunome-research.com/content/5/1/5
Page 5 of 12
(page number not for citation purposes)
and translation intensity are relatively well coupled upon
LPS-sensing, as suggested by the overall increase in pro-
tein synthesis at the onset of maturation. However, we
evaluate to 30% (the mean percentage of the genes unique
to polysomal RNA and total RNA) the proportion of trans-
lationally-engaged mRNA molecules, in which transcrip-
tion and translation are not linearly connected. The
polysome-bound (that is, translated) mRNAs were up-reg-
ulated and down-regulated with the same proportions
indicating that translation regulation in DCs is probably
targeting discrete subsets of genes, whereas the majority of
genes are regulated by transcription and mRNA stability, a
detailed description of these genes subsets is given in
Additional file 2. Most of the identified genes were distrib-
uted in all biological activities with no clear functional
clustering capable of unraveling a distinct pattern of regu-
lation. However, an over-representation of protein syn-
thesis genes was found in the genes identified as
translationaly down-regulated at late time of maturation
(see Additional file 2D).
Biological functions of translationally regulated mRNAs in 
activated moDCs
We decided to take a statistically unbiased approach to
further identify entire functional pathways, which could
be regulated at the translational level. Importantly, the
data obtained from four different donors were homoge-
nous and no major pattern variation for both total and
polysomal-bound RNA expression was found, thus allow-
ing statistical analysis (see Additional file 3, compare the
four columns within each T or P).
The 54'675 probe sets present on the Affymetrix Gene-
Chip array were first filtered on flags (P in 50% 0 h or P in
Global alterations of total and polysomal-bound mRNA in LPS-activated moDCsFigure 3
Global alterations of total and polysomal-bound mRNA in LPS-activated moDCs. The 54'675 probe sets present 
on the Affymetrix U133 Plus 2.0 GeneChip array were first filtered on expression (signal > 100 in all tested conditions) to 
obtain a preliminary list of 7'709 probe sets. The 7'709 probe sets were then filtered on fold change (applying a 2-fold cut-off) 
comparing Polysomal (Poly, red) and Total (Tot, blue) mRNA, between 0 h and 4 h (A and B) or 4 h and 16 h (C and D) post-
LPS. For effective Venn diagram visualization, the transcriptionally up-regulated probe sets (A and C) were distinguished from 
the transcriptionally down-regulated probe sets (B and D). See Additional file 3 for a detailed description of the different genes 
subsets.
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50% 4 h or P in 50% 16 h) to obtain a preliminary list of
20,438 probe sets. A 2-way ANOVA with repeats on time
was performed on 20,438 selected probe sets (using a
false discovery rate of 0.05). 375 probe sets (2%) had a
statistically significant interaction (Figure 4), indicating
that only a relatively small subset of mRNA molecules
were translationally regulated in LPS-activated moDCs
(complete list in Additional file 4). From this list of trans-
lationally regulated genes and using the Ingenuity Path-
way analysis software (IPA version 6.3), we were able to
identify several major "biological functions" controlled at
the post-transcriptional level during the activation of
moDCs (Table 1).
The biological function with the most significative p-value
for translational regulation was protein synthesis itself
(26 molecules), including 3 translation factors among
which was found eIF2α. Other identified pathways
included "post-transcriptional modification" and "amino
acid metabolism" comprising again some molecules
involved in protein synthesis and amino acid modifica-
tion (e.g. QARS, eIF4B, or INDO, DUSP2 and DUSP3).
As for molecules directly relevant to DC immune func-
tion, we identified genes involved in pathogen sensing
(e.g.: OAS1, OAS2, LY96), antigen processing (e.g.: TAP1
and TAP2), immune regulation (e.g.: IL-6, INDO, CD80,
SLP2) or leukocytes emigration (e.g. CXCL3 and CXCR4).
Clearly this list indicates that a number of mRNAs
expressed during DC maturation and important for their
immuno-modulatory function are regulated at the trans-
lational level, such as Indoleamine 2,3-dioxygenase (IDO
or INDO). IDO is a potent immuno-regulatory enzyme
that degrades the essential amino acid tryptophan and
results in a rise in uncharged tRNA, which activates the
GCN2 kinase and downstream signaling such as the phos-
phorylation of eIF2α. Thus, IDO is likely to be preferen-
tially translated in conditions of eIF2α phosphorylation
and might therefore be regulated at the translational level.
A subset of transcripts from the original list of 375 trans-
lationally regulated genes was selected for real-time PCR
validation (Table 2). The validation was performed on the
total RNA and the polysome-bound RNA populations, for
14 different genes directly relevant to DC biology (see
Additional file 5). The PCR results obtained on three inde-
pendent experiments confirmed the microarray data for
most of the selected genes, a fact further supported statis-
tically by applying the Spearman correlation method (see
Additional file 6). Although the level of translation regu-
lation is relatively weak for some of these genes (e.g.
TAP1, TAP2 or CASP9), several displayed a marked down-
regulation of translation engagement while transcription
remained unchanged (e.g. RPL 14 and RPL26 or MD2).
Specific ribosomal proteins are translationally regulated in 
activated moDCs
To complement the Ingenuity pathway analysis and iden-
tify co-regulated mRNAs during DC- activation, the 375
translationally regulated transcripts were clustered on a
heat-map using Genespring default setting. Once again,
the most obvious cluster of translationally regulated
mRNAs was a group of 11 different large ribosomal subu-
nit proteins and translation factor genes, which are part of
the protein synthesis pathway identified during the Inge-
nuity pathway analysis and validated by qPCR (Figure 5).
The gene expression signals for this cluster containing,
RPL3, RPL5, RPL7, RPL9, RPL13, RPL14, RPL15, RPL26,
RPL31, RPL37 and RPL38 was considerably reduced in the
polysomal-bound mRNAs compared to total mRNA sig-
nals at 0 h and 16 h post-LPS activation. Comparatively
no significant difference among the two RNA types was
Statistical approach to identify translationally-regulated mRNA molecules in LPS-ac iva ed moDCsFigure 4
Statistical approach to identify translationally-regu-
lated mRNA molecules in LPS-activated moDCs. The 
54'675 probe sets present on the Affymetrix U133 Plus 2.0 
GeneChip array were first filtered on flags (P in 50% 0 h or P 
in 50% 4 h or P in 50% 16 h) to obtain a preliminary list of 
20'438 probe sets. A 2-way ANOVA analysis with repeats on 
time (false discovery rate= 0.05) was then performed on the 
20'438 selected probe sets, to identify the 375 translation-
ally-regulated mRNA molecules with statistically significant 
interaction (red circle in Venn diagram). An example of inter-
action (the two curves are parallel between 0 h and 4 h and 
are "interacting" between 4 h and 16 h post-LPS) between 
Total and Polysomal mRNA is indicated on the simplified 
graph on left, where the different time points of the two 
RNA groups are connected by their mean gene expression 
signals. The number of probe sets belonging to each parame-
ter is indicated in brackets. See Additional file 4 for the com-
plete list of translationally-regulated mRNA molecules. 
Groups defined within each parameter, Time: 0 h, 4 h and 16 
h post-LPS; RNA type: Total mRNA and Polysomal mRNA.
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detected after 4 h of LPS stimulation, suggesting that these
RPL mRNAs were engaged in translation at this early time
of DC activation. Thus, RPL transcripts seem to undergo
"translational engagement" between 0 h and 4 h, fol-
lowed by "translational disengagement" between 4 h and
16 h, thus matching the observed rate of protein synthesis
in DCs. Transcription of ribosomal protein genes starts at
a C-residue that is embedded in an oligopyrimidine tract
of length 5-25 base pairs, also known as the 5'-TOP signal.
The 5'-TOP signal is an essential cis-regulatory motif for
the translational control of most ribosomal protein
mRNAs expression [18,19]. A preponderance of evidence
suggests that translation of mRNAs containing a 5'-TOP
signal is strongly up-regulated in response to ribosome
protein S6 phosphorylation triggered by mTORC1 stimu-
lation and subsequent S6K1 activation. In addition to
ribosomal proteins mRNAs, TOP mRNAs include also
those coding for several translation elongation factors
such as eEF2, indicating that most of the translationally
down-regulated genes identified in DCs during their
response to LPS contain a 5'-TOP signal.
In recent years, several reports have also suggested that
translation of TOP mRNAs can be independent of S6
phosphorylation [20,21]. In activated DCs, S6 phosphor-
ylation correlates well with the translational engagement
of the ribosomal proteins after 4 h of LPS stimulation
(Figure 5, 4h). However even if the intensity of S6 phos-
phorylation keeps increasing during the following 12 h of
DC maturation, several of the large ribosomal protein
mRNAs are nevertheless clearly disengaged from polys-
omes. Thus, although S6 phosphorylation is likely to
favor translational engagement of 5'-TOP containing
mRNAs, it does not counteract their increased release
from the ribosomes.
A role for ribosome proteins (RLP) outside of translation
is emerging, however most of the current knowledge
about these proteins links them with specific translation
regulation activity including ER-binding for RLP7 and
control of survival for RPL5, 11, 23 and 26 [22]. Indeed,
these particular RLPs are involved in the murine double
minute protein (MDM2)-mediated p53 pathway regula-
tion [23]. Mdm2 is a E3-ubiquitin ligase known to regu-
late p53 levels directly by promoting its degradation and
indirectly by targeting ribosomal protein L26, which nor-
mally binds the p53 mRNA and augments its translation.
As the ribosomal protein L26 (RPL26) represents an
important component of the auto-regulatory feedback
loop that maintains low p53 activity in non-stressed cells
[22], we further investigated the regulation of RPL26 at
the mRNA and protein levels in activated DCs. Although
RPL26 mRNA gene expression was stable upon-LPS stim-
ulation, its polysomal-bound engagement was lost at 16
h, as identified by microarrays and confirmed by qPCR
(Figure 6A). More importantly, RPL26 protein expression
was down-regulated by 80% after 16 h of LPS- mediated
activation, correlating with the down-regulation of polys-
omal-bound mRNAs (Figure 6B).
The translation regulation of ribosomal protein mRNAs is
one of the features of LPS-activated human DCs. In the
early phase of DC maturation, a specific increase in ribos-
osomal proteins synthesis might impact positively on the
Table 1: Top "biological functions" of mRNA molecules affected by translation regulation in LPS-activated moDCs
Category 
(nr. of molecules)
Biological Function p-value Molecules (gene symbols)
Protein Synthesis (26) biosynthesis of proteins and translation 
regulation
1.73E-04 ADAMTS5, CASP9, EEF2, EIF2A, EIF4A2, EIF4B, NCK1, 
PLAU, PSMC2, RBM3, RPL3, RPL5, RPL7, RPL13, RPL14, 
RPL15, RPL26, RPL31, RPL37, RPL38, RPL9, RPS11, 
SERPINB1, SRGN, UBC, UBE2K
RNA Post-Transcriptional 
Modification (12)
modification of mRNA 8.67E-03 CDC5L, CPSF1, DBR1, EIF4A2, EIF4B, GRSF1, HNRNPR, 
CPSF1, GRSF1, MAPKAPK2, ZFP36, QARS
Amino Acid Metabolism (11) catabolism of L-tryptophan and 
dephosphorylation of amino acids
8.57E-08 CD80, IL6, INDO, KMO, KYNU, DUSP2, DUSP3, 
PPM1A, PPM1F, PPP1CB, PTPN6
Cell Morphology (10) transmembrane potential of 
mitochondria
1.26E-03 AP2A2, BNIP3, CASP9, CFLAR, IL6, MAPK9, MOAP1, 
NFE2L2, PTPN6, SRGN
Immune Cell Trafficking (8) emigration of leukocytes 2.08E-03 CD44, CXCL3, CXCR4, CYTIP, GFI1, LDLR, PLAU
Cancer (7) tumorigenesis of intestinal tissue 2.64E-03 APC, MLH1, IFI16, SMARCA2, HSPA1A, IFI16, IGFBP4
Nucleic Acid Metabolism (5) metabolism of nucleic acid component 6.15E-04 ATIC, MTAP, OAS1, OAS2, REXO2
Cell-mediated Immune 
Response (4)
secretion of cytokine 3.60E-03 CADM1, LCP2, SRGN, GFI1
Antigen Presentation (2) antigen peptide transporter 8.84E-03 TAP1, TAP2
Small molecule biochemistry 
(1)
activation by LPS 4.21E-02 LY96 (MD2)
The 375 probe sets with statistically significant interaction (Additional file 4) have been analysed with the Ingenuity Pathway software. The table 
displays the 10 most significant biological "categories" affected by translation regulation (out of 29 found), ranked by the number of molecules per 
category. The significance is expressed as p-value and is based on a Fisher's exact test, calculated by the software itself. The translationally regulated 
mRNA molecules validated by qPCR are indicated in bold (Table 2). RPL26 has been also validated at the protein level and is underlined (Figure 6).
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global translation enhancement in response to TLR-4
engagement and subsequent PI3K activation, while a
reduction at later time might favor a decrease in transla-
tion intensity. The reduction in RPL26 might also have a
specific effect on the survival of activated DCs. Although
many aspects of the non-translational role of ribosomal
proteins remain to be investigated, it is noteworthy to
underline that several ribosomal protein (RLP4, RLP22
and RLP35) and translation factors (eEF1d) mRNAs repre-
sent the most significant genes up-regulated in a statistical
group comparison performed to identified genes differen-
tially expressed in Systemic onset juvenile idiopathic
arthritis (SoJIA) patients compared with healthy children
[24]. SoJIA patients are also characterized by abundant
production of interleukin (IL)-1, which is an important
mediator of this disease and can be induced in DCs by
LPS, thus creating an additional link between 5'-TOP con-
taining mRNAs and inflammatory conditions. Our results
on the characterization of RPL26 mRNA and its protein
expression strongly support our conclusion that other RLP
genes belong to a cluster being translationally regulated
during DC maturation. Translation regulation therefore
appears as a key function to control specific gene expres-
sion and more precise analysis combining traditional
gene expression arrays and translation profiling will have
to be carried-out to follow the immune response and
host-pathogen interactions and single-out functionally
important mRNAs regulated at the translation level.
Methods
Cell Culture
Fresh human leukapheresis products were obtained from
the EFS (Marseille, France). Human peripheral blood
mononuclear cells (PBMC) were isolated by Ficoll-
PaqueTM PLUS (Amersham Biosciences, Uppsala, Swe-
den), washed four times with RPMI and CD14+ cells were
immunomagnetically purified with AutoMACS system
following the protocol of the manufacturer (Miltenyi Bio-
tech, Auburn, CA). Purified CD14+ monocytes were ana-
lyzed using a FACSCalibur (Becton Dickinson, San Jose,
CA), confirming the purity of CD14+ cells to be 95%. To
promote differentiation into iDC, the purified CD14+ cells
(0.5 × 106 cells/ml) were plated in 6-well plates (2 × 106
cells/well) and cultured in RPMI 1640 medium supple-
mented with 10% FCS, non essential amino acids, penicil-
lin/streptomycin 100 ng/mL (>1000 U/ml), recombinant
Table 2: Validation of the array data by real time PCR using total and polysome-bound RNA populations.
Gene Symbol Affy probe set RNA type Fold change (p-value) Array Fold change (+/- SD) qPCR
4 h vs 0 h 16 h vs 4 h 4 h vs 0 h 16 h vs 4 h
IL-6 205207_at Poly 503,11 (0,040) -7,3 (0,101) 3641,21 (11,92) -58,26 (1,21)
Tot 239,22 (0,010) -7,3 (0,051) 2017,22 (19,13) -12,95 (2,11)
RPL26 222229_x_at Poly 1,41 (0,205) -1,78 (0,044) 1,81 (0,32) -1,06 (0,33)
Tot -1,36 (0,129) -1,33 (0,321) -3,12 (0,41) -1,52 (0,34)
RPL14 213588_x_at Poly 1,45 (0,008) -1,47 (0,101) 0,31 (0,12) -0,81 (0,22)
Tot -1,1 (0,191) -1,17 (0,089) -1,31 (0,32) -1,29 (0,33)
RPS23 200926_at Poly 1,73 (0,099) -2,74 (0,100) 0,72 (0,13) -2,52 (0,35)
Tot 1,05 (0,011) -1,72 (0,111) 0,32 (0,14) -1,89 (0,07)
CD80 1554519_at Poly 22,81 (0,133) 1,31 (0,002) 19,71 (0,72) 0,77 (0,22)
Tot 33,65 (0,001) 1,43 (0,005) 22,71 (1,52) 0,41 (0,11)
OAS1 202869_at Poly 11,56 (0,048) 1,36 (0,044) 7,26 (1,24) 1,74 (0,71)
Tot 13,12 (0,026) 1,86 (0.003) 12,32 (0,32) 1,26 (0,11)
OAS2 204972_at Poly 34,15 (0,043) -1,16 (0,111) 7,51 (0.12) 1,48 (0,45)
Tot 23,5 (0,001) 1,2 (0,011) 5,91 (0,11) 1,21 (0,22)
CASP9 203984_s_at Poly -3,94 (0,011) 2,92 (0,009) -14,71 (1,3) 2,79 (0,81)
Tot -3,74 (0,005) 2,02 (0,001) -11,7 (2,1) 3,09 (0,62)
HLA-F 221875_x_at Poly 2,07 (0,021) 1,21 (0,008) 3,41 (0,42) 1,97 (0,32)
Tot 1,92 (0,002) 1,97 (0,007) 2,31 (0,71) 2,25 (0,55)
INDO 210029_at Poly 117,32 (0,022) 1,34 (0,001) 1176,21 (8,33) 2,01 (0,26)
Tot 97,51 (0,011) 1,91 (0,008) 737,2 (3,55) 2,54 (0,27)
TAP1 202307_s_at Poly 6,62 (0,340) 1,02 (0,009) 4,71 (1,1) 0,79 (0,20)
Tot 8,38 (0,013) 1,31 (0,002) 6,2 (0,89) 1,55 (0,41)
TAP2 225973_at Poly 3,19 (0,001) 1,56 (0,111) 3,01 (0,66) 1,62 (0,61)
Tot 3,20 (0,013) 1,95 (0,505) 3,21 (0,52) 1,93 (1,10)
MD2 206584_at Poly -1,37 (0,008) -3,43 (0,043) -2,91 (0,77) -3,30 (0,21)
Tot 1,11 (0,008) -2,31 (0,002) 1,51 (0,33) -2,10 (0,41)
eIF4B 211938_at Poly -2,26 (0,001) -1,65 (0,031) -2,21 (0,23) 0,87 (0,04)
Tot -3,81 (0,006) -1,66 (0,003) -17,91 (2,21) 0,35 (0,02)
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human GM-CSF and 20 ng/mL (>100 U/ml) IL-4 for 5
days (both from PeproTech, Rocky Hill, NJ). At days 2 and
4, half of the volume of the medium was replaced by fresh
medium supplemented with GM-CSF and IL-4. For DC
maturation, 100 ng/mL LPS (Escherichia coli type 026:B6;
Sigma-Aldrich, St. Louis, MO) was added to the cells at
day 5, for the indicated number of hours.
Polysomal profiling by sucrose gradient fractionation
Polysome-bound mRNA molecules were enriched by
sucrose gradient fractionation following the protocol orig-
inally developed by Garcia-Sanz and collaborators [25].
Briefly, 60 to 80 × 106 day 5 human moDCs were lysed in
1 ml of polysome buffer (10 mM Tris-HCl (pH 8), 140
mM NaCl, 1.5 mM MgCl2, 0.5% NP40, 0.1 mg/ml
cycloheximide, and 500 units/mL RNasin (Promega,
Madison, WI). After 10 min on ice, lysates were quickly
centrifuged (10.000 × g for 10 sec at 4°C) and the super-
natant was resuspended in a stabilizing solution (0.2 mg/
ml cycloheximide, 0.7 mg/ml heparin, 1 mM phenyl-
methanesulfonyl fluoride). After a quick centrifugation
(12.000 × g for 2 min at 4°C) to remove mitochondria
and membrane debris, the resulting supernatant was lay-
ered on a 15% to 40% sucrose gradient. Gradients were
then ultracentrifuged (35.000 × g for 2 h at 4°C, SW41
rotor) and after centrifugation 20 × 550 ml fractions were
collected, starting from the top of the gradient. All the
fractions were then digested with Proteinase K (200 mg/
ml) in presence of 1%SDS and 10 mM EDTA. RNA was
then extracted with Phenol/Chloroform/Isoamylalcohol
(volume ratio 25:24:1) and precipitated with 2.5 Volumes
of 100% Ethanol in presence of 0.8 M lithium chloride,
Specific ribosomal protein mRNAs are translationally-regulated in LPS-activated moDCsFigure 5
Specific ribosomal protein mRNAs are translationally-regulated in LPS-activated moDCs. The 375 mRNA mole-
cules with statistically significant interaction (see Figure 4) were clustered on a heat-map using the software GeneSpring GX 
7.3. The translationally regulated ribosomal protein mRNAs appear as a specific signature (left panel), which has been extracted 
and enlarged (right panel). See the text for more details.
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necessary to get rid of heparin, a known inhibitor of RT
activity [26]. After precipitation all the RNA were resus-
pended in 20 ml RNase free H2O. The correct fractiona-
tion of the polysomes was tested by detecting the different
rRNA types on a 1% denaturing agarose gel. Total RNA
was directly extracted out of moDCs without fractiona-
tion. Total and polysomal-bound RNAwere purified using
the RNeasy miniprep kit (Qiagen, Chatsworth, CA). To
exclude theamplification of genomic DNA, an on-column
DNase digestion was performed using the RNase-Free
DNase Set (Qiagen). The RNA Integrity Number (RIN-
value) of all RNA types and timepoints was measured with
the Agilent 2100 Bioanalyzer. RIN-values between 6.5 and
8.5 (mean RIN value = 7.6) were obtained, indicating that
the RNA had sufficient integrity to be analyzed by micro-
arrays.
Affymetrix microarray hybridization and data mining
For each condition 100 ng of total or polysomal-bound
RNA were employed to synthesize double-stranded cDNA
using two successive reverse-transcription reactions
according to standard Affymetrix protocols (GeneChip
Two-Cycle Target Labelling, Affymetrix, Santa Clara, CA).
Linear amplification with T7-RNA polymerase and biotin
labelling were performed by in vitro transcription by
standard Affymetrix procedures. The resulting biotin-
labeled cRNA was fragmented and hybridized to the
Affymetrix Human Genome U133 2.0 oligonucleotide
14,500-gene microarray chip for 16 h at 45°C. Following
hybridization, the probe array was washed and stained on
a fluidics station and immediately scanned on a Affyme-
trix GCS 3000 GeneArray Scanner. The data generated
from the scan were then analyzed using the MicroArray
Suite software (MAS 5.0, Affymetrix). The data derived
from four independent experiments were normalized
using the GC-RMA algorithm and bioinformatic analysis
was performed using GeneSpring GX 7.3 (Agilent, Palo
Alto, CA) and Statistics Analysis System (SAS v9.1.3).
Probe selection was performed using 2-way ANOVAs
accounting for repeated measures with a false discovery
rate of 0.05. Hierarchical clustering was performed using
the default clustering algorithm and setting in GX7.3.
Quantitative real-time RT-PCR
Total RNA was extracted and purified using the RNeasy kit
(Qiagen). To exclude the amplification of genomic DNA,
an on-column DNase digestion was performed using the
RNase-Free DNase Set (Qiagen). 1 μg of RNA was retro-
transcribed using SuperScript II reverse transcriptase (Inv-
itrogen) and random (pDN6) primers. First-strand cDNA
templates were then used for PCR amplification of short
(100 to 150 bp) exon fragments of the gene of interest
using the appropriate primers (Additional file 4 shows the
complete list of the 375 probe sets with statistically signif-
icant interaction). PCR was carried out using a Stratagene
MX3000P Real-Time PCR System in complete SYBR Green
PCR buffer (PE Biosystems, Warrington, UK) using 200
nM of each specific primer. A total of 20 μl of PCR mix was
added to 5 μl of cDNA template, and the amplification
was tracked via SYBR Green incorporation by using a
Stratagene (La Jolla, CA) sequence detection system 4.01.
Comparative real-time PCR was done in triplicate, includ-
ing no-template controls. A dissociation curve was gener-
ated at the end of each PCR cycle to verify that a single
product was amplified. Relative quantification of target
cDNA was determined by calculating the difference in
cross-threshold (Ct) values after normalization to GAPDH
signals, according to the Pfaffl method and the automated
Excel-based program available (REST©). The sequences of
all employed primers are available in Additional file 7.
Immunodetection and antibodies
50 μg of TX-100 soluble material or 200.000 cells, lysed
directly in Laemmli buffer, were loaded on 10% SDS-
PAGE prior to immunoblotting and chemiluminescence
detection (SuperSignal, Pierce, USA). SUnSET was per-
Correlation between RPL26 mRNA translational disengage-ment and protein down-regulation in LPS- ctivate  moDCsFigure 6
Correlation between RPL26 mRNA translational dis-
engagement and protein down-regulation in LPS-
activated moDCs. (A) Gene expression of the RPL26 
Total and Polysomal mRNAs determined by microarrays 
analysis (left) and confirmed by qRT-PCR analysis (right), 
depicted as fold induction between 4 h and 0 h and 16 h and 
4 h post-LPS. (B) Immunoblot to assay RPL26 protein 
expression at 0 h, 4 h and 16 h post-LPS. An actin immunob-
lot is shown for equal loading control. The relative protein 
expression (top) has been determined by quantifying the 
immublot signals with the software ImageQuant (Fuji) and is 
representative of a typical experiment (n = 3).
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formed as previously described [14] using A647-labelled
mouse IgG2a anti-puromycin antibody (12D10). Anti-
body against RPL26 was from Abnova. For flow cytometry
analysis, APC-conjugated anti-HLA-DR (L243 clone) and
PE-conjugated anti-CD86 (clone IT2.2) were from BD
PharMingen (San Jose, CA, USA). Anti- eIF2, phospho-
eIF2 and -phospho-S6 were from Cell Signaling Technol-
ogy (Beverly, MA, USA). For immunofluorescence analy-
sis, MoDCs were let adhere on Alcyan blue coated-
coverslips and surface stained with unlabelled antibody at
4°C for 30 min. After washes, coverslips were placed in
warm medium for the indicated time and then fixed in 3%
PFA for conventional staining with secondary antibodies.
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